Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wanna see something funny janice?https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169981187
Kinda like MULN's pps. "Of Napoleon’s 600,000 troops who began the campaign, only an estimated 100,000 made it out of Russia."
Delivered plenty of his own dead men, unfortunately.
Maybe david is napoleón reincarnated.
Some Wes Christian loons too janice, lol.https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170987076
MULN had naked short loons recently.https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154990658
How about an exchange note possibility.https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172748545
Tbh, david is already set for a comfortable retirement. In my eyes he did everything legally and sleeps fine. I think bollinger will succeed as a private company and mullen will burn out.
"It's better to burn out than to fade away"- Neil Young
We'll smack shorts like a paddle ball. The idiots won't know what hit em until a margin call sends them to tom sellick to sign a reverse mortgage to cover, lol.
I like 96% inst owned.https://finviz.com/quote.ashx?t=CCCC&p=d
Good point uber! MULNrulesbtw, lol.
Oh no...not another broken caps lock issue. Seriously...if MULN gets artificially pushed, shorting it can be costly. There are plenty of ways to make good money other than taking unnecessary risks. Go to C4 therapeutics(cccc) and make money in a 96% institution owned stock on the rise. I'm simply not fond of shorting or broken cap lock buttons. Below is an example of what can happen when a MULN short position goes wrong.
$$$MULN#&%$$Actually, they do a great deal of good together through being peaceful in their decision making, although divorced. Bitter divorces accomplish nothing and stops people from working together. Especially when they have accomplished so much as bill and melinda have. George foreman said it best when he said..."If it isn't positive. I don't hear it." Well said george! Denzel had a slightly different quote that I like as well.
MULN$$WT...$$First...warren was simply passing on a good advice universal statement. Secondly...bill and melinda are wonderful people going two different paths with their time in their latter years. They still have a close relationship. Thirdly...MULN is an addictive soap opera not worth posting david's antics anymore. Trying to out run a lion is more fun than wondering what press release david will issue next.
C4 (CCCC) Up 6% on Restructuring Plan to Curb Cash Burn
"Shares of C4 Therapeutics (CCCC - Free Report) , or C4T, were up 5.8% on Jan 10 after management announced strategic plans to prioritize its drug development efforts in 2024.CCCC seeks to prioritize the advancement of two of its pipeline candidates, CFT7455 and CFT1946, both of which are in early-stage development. While CFT7455 is being developed in a phase I/II study for multiple myeloma (MM) and non-Hodgkin’s lymphoma (NHL) indications, CFT1946 is being evaluated in a separate phase I/II study for treating BRAF V600 mutant solid tumors including non-small cell lung cancer (NSCLC), colorectal cancer and melanoma.
The company also intends to advance its partnered programs. It intends to support its partner, China-based Betta Pharmaceuticals, in initiating clinical development on CFT8919 in EGFR L858R mutated NSCLC patients. C4T also plans on expanding its collaborations with Merck (MRK - Free Report) , Biogen and Roche.To achieve these objectives, C4 Therapeutics will reduce its existing workforce by 30%. It reported about $330 million in unaudited cash, cash equivalents and marketable securities as of Jan 5, compared with $246.4 million balance as of Sep 30, 2023.Earlier this month, C4T closed a $25-million equity investment from Betta Pharmaceuticals. It also signed a collaboration deal with Merck last month to develop novel oncology drugs, for which the company also received a $10 million upfront payment. During fourth-quarter 2023, C4 also sold shares to the public as part of an at-the-market (ATM) offering, raising $72 million in net proceeds.C4T expects the additional capital and cost-saving efforts to extend its cash runway into 2027.Alongside the prioritization efforts, management also announced set milestones for the year. These include updated data from the ongoing phase I dose escalation studies on CFT7455 in MM and NHL indications before the year's end. It also expects a data readout in the second half of the year from the early-stage dose escalation study on CFT1946 in BRAF V600 mutated cancers.
In the past year, shares of C4T have lost 9.3% compared with the industry’s 10.9% decline.Zacks Investment Research
Image Source: Zacks Investment ResearchDecember 2023 was an important month for C4T. During this month, the company signed a collaboration deal with Merck to discover and develop degrader-antibody conjugates (DACs), with an initial focus on one oncology target. CCCC is also eligible to receive milestone payments from Merck of around $600 million and tiered royalties on net sales if a product is commercialized upon potential approval.In the same month, C4T also reported encouraging data from the phase I/II study on CFT4755. Data from the study showed that treatment with CFT4755 led to anti-myeloma activity in patients who had undergone numerous lines of prior therapy for multiple myeloma, including BCMA therapies.C4T’s top line currently comprises collaboration revenues. Hence, in the absence of a marketed product, the successful development of its pipeline candidates remains the key focus for the company. However, any regulatory or developmental setback for its candidates is likely to hurt the stock in the days ahead."
(Updated)"C4T expects the additional capital and cost-saving efforts to extend its cash runway into 2027."
Great article subs! It's the first news article after searching cccc.
https://www.zacks.com/stock/news/2209026/c4-cccc-up-6-on-restructuring-plan-to-curb-cash-burn
MULN$LOL$...smokin joe came to our small local gym when I was boxing back in the 1980's. His son, Joe jr, had a fight that weekend with a 25-5 record if I remember correctly. After he ko'd his opponent that saturday Joe sr threw him over his shoulder and carried him around the ring like a rag doll. One proud papa indeed! Joe sr's hands were amazingly huge to see in person. As most heavyweight champions with integrity, he was great at giving back to the community and working with youth organizations to help make an impact at an early age. As mean and brutal as Sonny Liston was in the ring as a heavyweight champion in his era, Sonny was truly inspiring to youth organizations as he spent alot of time mentoring troubled youngsters. My hats off to Sonny, joe and all the others with great integrity that took the time to make a positive difference in the lives of people inside and outside of their families lives. That's my "down goes frazier" rebuttal, since dave is doing a great job of humoring us with MULN. Once again...MULN is a soap opera, not an investment.
Agree subs! C4 is sanity. Outside, not so much. I watched an old episode of "Wanted: Dead or Alive" with Steve McQueen recently. An old cowboy asked him..."you don't like having friends do you?". Steve replied..."sure I do. Just not the ones I have to associate with". I like his attitude. I think I'll binge watch it later. I appreciate brutal honesty.
You're very kind subs. Newbie should thank you.
Wanna borrow my reading glasses?https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173441840
(Interesting as well) "In the next couple of years, he’s hoping to launch a consumer-friendly energy storage device made with second-hand EV batteries. The increasing surplus of former EV batteries piling up around the country means that he can take his pick: “We’re finding, basically, they’re all in really good condition.”